Clinical Trials
0
Active:0
Completed:0
Trial Phases
0 Phases
Drug Approvals
2
NMPA:2
Drug Approvals
Eribulin Mesilate Injection
- Product Name
- 甲磺酸艾立布林注射液
- Approval Number
- 国药准字HJ20190042
- Approval Date
- Feb 7, 2024
NMPA
Eribulin Mesilate Injection
- Product Name
- 甲磺酸艾立布林注射液
- Approval Number
- H20190042
- Approval Date
- Jul 12, 2019
NMPA
Clinical Trials
No trials found
News
No news found